FDA Safety Communication Date Issued: January 3, 2024 The U.S. Food and Drug Administration (FDA) is providing recommendations for healthcare providers considering using the Total Hip System, including resurfacing implants, manufactured by Synovo Production, Inc. (Synovo) and for patients who may have received certain implants used in the Synovo Total Hip System after 2019. Three […]